NICE has assessed viscoelastometric point-of-care testing devices, to help the NHS (National Health Service) to decide whether the use of these products is clinically and cost-effective.
Viscoelastometric point-of-care testing may be useful to help determine if bleeding is based on a reduced blood’s ability to clot or due to surgical reasons. This helps the doctor choosing the right treatment to stop bleeding. Using these systems may mean that patients are less likely to be transfused during and after surgery and to have to undergo revision surgery due to ongoing bleeding.
NICE has recommended viscoelastic testing devices – the ROTEM® system from Tem International GmbH – to help detect and manage life-threating bleeding in patients during and after cardiac surgery.
The NICE’s Health Technologies Adoption program works together with NHS centers to gain and share their experiences in using viscoelastometric point-of-care testing devices with other centers which may want to start using one […]